The revision of the Declaration of Helsinki: past, present and future

被引:447
作者
Carlson, RV
Boyd, KM
Webb, DJ
机构
[1] Univ Edinburgh, Western Gen Hosp, Clin Res Ctr, Clin Pharmacol Unit, Edinburgh EH4 2XU, Midlothian, Scotland
[2] Univ Edinburgh, Med Teaching Org, Edinburgh, Midlothian, Scotland
关键词
justice; Nuremberg Code; placebo-controlled trial; publication bias; research ethics; World Medical Association;
D O I
10.1111/j.1365-2125.2004.02103.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The World Medical Association's Declaration of Helsinki was first adopted in 1964. In its 40-year lifetime the Declaration has been revised five times and has risen to a position of prominence as a guiding statement of ethical principles for doctors involved in medical research. The most recent revision, however, has resulted in considerable controversy, particularly in the area of the ethical requirements surrounding placebo-controlled trials and the question of responsibilities to research participants at the end of a study. This review considers the past versions of the Declaration of Helsinki and asks the question: How exactly has the text of the Declaration changed throughout its lifetime? Regarding the present form of the Declaration of Helsinki we ask: What are the major changes in the most recent revision and what are the controversies surrounding them? Finally, building on the detailed review of the past and present versions of the Declaration of Helsinki, we give consideration to some of the possible future trajectories for the Declaration in the light of its history and standing in the world of the ethics of medical research.
引用
收藏
页码:695 / 713
页数:19
相关论文
共 53 条
  • [1] [Anonymous], 1964, BMJ-BRIT MED J, V2, P177
  • [2] [Anonymous], 2003, LANCET, V362, P1005
  • [3] [Anonymous], DECL HELS
  • [4] [Anonymous], 1964, DECL HELS
  • [5] Placebo-controlled studies in depression:: necessary, ethical and feasible
    Baldwin, D
    Broich, K
    Fritze, J
    Kasper, S
    Westenberg, H
    Möller, HJ
    [J]. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2003, 253 (01) : 22 - 28
  • [6] BEAUCHAMP TL, 2001, PRINCIPLES BIOMEDICA, P226
  • [7] The placebo effect in cardiovascular disease
    Bienenfeld, L
    Frishman, W
    Glasser, SP
    [J]. AMERICAN HEART JOURNAL, 1996, 132 (06) : 1207 - 1221
  • [8] Is the use of placebo controls ethically permissible in clinical trials of agents intended to reduce fractures in osteoporosis?
    Brody, BA
    Dickey, N
    Ellenberg, SS
    Heaney, RP
    Levine, RJ
    O'Brien, RL
    Purtilo, RB
    Weijer, C
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (06) : 1105 - 1109
  • [9] CAPRON AM, 2003, WMA COUNC M DIV BAIN
  • [10] One standard, not two
    Carlson, R
    Boyd, K
    Webb, D
    [J]. LANCET, 2003, 362 (9397) : 1761 - 1761